MitoChem Therapeutics

0 followers

With funding from Foundation Fighting Blindness and the NIH the company synthesized compounds that demonstrate promise for treating vision loss from retinitis pigmentosa, age-related macular degeneration and glaucoma.

Industries

Employees

11-50

Links


Org chart

President & CEO
Collapse
Co-Founder & CSO